Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus

Whitcomb David C.; Bodhani Amit; Beckmann Katrin; Sander-Struckmeier Suntje; Liu Shufang; Fuldeore Mahesh; Pollack Paul F.; Khurmi Rupal P.

首页> 外文期刊>Pancreas >Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus

【24h】

Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus

机译：胰酶/胰酶在外分泌型胰腺功能不全和糖尿病病史中的疗效和安全性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: The aim of this study was to perform exploratory analyses of the efficacy and safety of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency (EPI) with (n = 36) and without (n = 18) concurrent diabetes mellitus (DM).

机译：目的：本研究的目的是对胰脂肪酶缓释胶囊（Creon）在外分泌型胰腺功能不全（EPI）合并（n = 36）和不合并（n = 18）合并糖尿病的患者中的疗效和安全性进行探索性分析。（DM）。

著录项

来源
《Pancreas》 |2016年第5期|共8页
作者
Whitcomb David C.; Bodhani Amit; Beckmann Katrin; Sander-Struckmeier Suntje; Liu Shufang; Fuldeore Mahesh; Pollack Paul F.; Khurmi Rupal P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
exocrine pancreatic insufficiency; pancrelipase/pancreatin; diabetes mellitus;

机译：外分泌型胰腺功能不全;胰酶/胰酶;糖尿病;

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus [J] . Whitcomb David C., Bodhani Amit, Beckmann Katrin, Pancreas . 2016,第5期

机译：胰酶/胰酶在外分泌型胰腺功能不全和糖尿病病史中的疗效和安全性
2. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. [J] . Ewald N, Bretzel RG, Fantus IG, Diabetes/metabolism research and reviews . 2007,第5期

机译：根据粪便弹性蛋白酶1的低浓度，对接受胰岛素治疗的糖尿病和外分泌型胰腺功能不全的患者进行胰酶治疗。前瞻性多中心试验的结果。
3. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis [J] . RameshH., ReddyN., BhatiaS., Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] . 2013,第2期

机译：在印度进行的一项为期51周的开放标签临床试验，以评估胰酶40000肠溶微球对慢性胰腺炎引起的胰腺外分泌功能不全患者的疗效和安全性
4. The Proteomic Analysis of Pancreatic Exocrine Insufficiency Protein Marker in Type 2 Diabetes Mellitus Patients [C] . Arie Srihardyastutie, D W Soeatmadji, Fatchiyah International Conference on Chemistry and Material Science . 2018

机译：2型糖尿病患者胰腺外蛋白蛋白标志物的蛋白质组学分析
5. A cross-sectional examination: Impact of diet and physical activity on plasma glucose metabolism, insulin sensitivity and pancreatic B-cell function in Hispanic women with histories of gestational diabetes mellitus [D] . Liu, Xinwen 2009

机译：横截面检查：饮食和身体活动对妊娠期糖尿病历史历史血浆妇女血浆葡萄糖代谢，胰岛素敏感性和胰腺B细胞功能的影响
6. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind placebo-controlled study [O] . V Thorat, N Reddy, S Bhatia, -1

机译：一项随机临床试验：胰酶肠溶微球（Creon 40000 MMS）在慢性胰腺炎引起的胰腺外分泌功能不全患者中的有效性和安全性-一项双盲安慰剂对照研究
7. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis [O] . Konstan, Michael W., Liou, Theodore G., Strausbaugh, Steven D., 2010

机译：新型胰酶（Ultrase MT20）治疗囊性纤维化外分泌胰腺功能不全的吸收不良的疗效和安全性

Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus

摘要

著录项

相似文献

相关主题

期刊订阅